Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2006 03:30 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Launch of THELIN in United Kingdom

HOUSTON, Nov. 6, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium)(2) 100 mg tablets in the United Kingdom for...
November 02, 2006 16:40 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Submits Complete Response to FDA For Thelin New Drug Application

HOUSTON, Nov. 2, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced that following discussions today with the U.S. Food and Drug Administration (FDA), the Company has submitted a...
November 02, 2006 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports Third Quarter 2006 Financial Results

HOUSTON, Nov. 2, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the third quarter ended September 30, 2006. Third Quarter Financial Overview ...
October 19, 2006 18:45 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Secures Equity Financing Commitment

HOUSTON, Oct. 19, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has secured a commitment for up to $75 million in a common stock equity financing from Azimuth...
October 16, 2006 16:45 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2006 Results

HOUSTON, Oct. 16, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Thursday, November 2, 2006 at 8:00 a.m. ET to discuss its third quarter 2006...
August 11, 2006 13:16 ET | Source: Encysive Pharmaceuticals Inc.

THELIN (Sitaxentan Sodium) Receives European Marketing Authorization for Treatment of Pulmonary Arterial Hypertension

European Commission Grants First Selective, Once Daily Oral Endothelin A Receptor Antagonist Approval in All 25 European Union Member States Conference Call Scheduled for Monday, August...
August 10, 2006 15:18 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Receives Notification of Marketing Authorization From European Commission Regarding THELIN (Sitaxentan Sodium)

HOUSTON, Aug. 10, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) was notified today that the European Commission has adopted the decision granting marketing authorization for THELIN(r)(1)...
August 07, 2006 07:02 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports Second Quarter 2006 Financial Results

HOUSTON, Aug. 7, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the second quarter ended June 30, 2006. Second Quarter Financial Overview --...
July 27, 2006 08:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2006 Results

HOUSTON, July 27, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Monday, August 7, 2006 at 8:00 a.m. ET to discuss its second quarter 2006...
April 28, 2005 16:01 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports First Quarter 2005 Financial Results

HOUSTON, April 28, 2005 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the first quarter ending March 31, 2005. "In the first quarter, we saw the...